A Study to Test Different Doses of BI 456906 in Patients With Obesity
Launched by BOEHRINGER INGELHEIM · Jul 9, 2018
Trial Information
Current as of May 23, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male and female patients ≥ 18 years and \< 70 years of age at screening
- • Body Mass Index (BMI) ≥ 27 kg/m2 and \<40 kg/m2 at screening
- • A minimum absolute body weight of 70 kg at screening and a stable body weight (defined as no more than 5% change) 3 months prior to screening
- • HbA1c \<6.5%
- • Further inclusion criteria apply
- Exclusion Criteria:
- • Women who are pregnant, nursing, or who plan to become pregnant while in the trial
- • Supine blood pressure (BP) ≥160/100 mmHg at screening
- • Major surgery (major according to the investigator's assessment) performed within 12 weeks prior to randomization or planned within 12 months after screening
- • Any laboratory value outside the reference range that the investigator considers to be of clinical relevance
- • Further exclusion criteria apply
About Boehringer Ingelheim
Boehringer Ingelheim is a global, research-driven pharmaceutical company dedicated to improving health and quality of life through innovative therapies. Established in 1885 and headquartered in Ingelheim, Germany, the company focuses on the development of prescription medicines in key therapeutic areas, including respiratory diseases, cardiovascular health, oncology, and immunology. Boehringer Ingelheim is committed to advancing medical science through rigorous clinical trials and collaborative research, striving to bring novel treatments to patients while upholding the highest standards of safety and efficacy. With a strong emphasis on sustainability and corporate responsibility, the company aims to make a meaningful impact on global health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Neuss, , Germany
Mainz, , Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials